Effect of Co-consuming Different Dietary Protein Sources With Salad on the Bioavailability of Carotenoids
2 other identifiers
interventional
19
1 country
1
Brief Summary
The goal of this clinical trial is to learn if different protein types will affect carotenoid responses in humans when co-consumed with salad. The main questions it aims to answer are:
- What are the effect of dietary protein co-consumption with salad on postprandial carotenoid levels in Singapore adults?
- Do different whole-food protein sources enhance the bioavailability of carotenoids in Singapore adults? Participants will: Consume salad with a form of protein (chicken, tuna, egg, soybean) Have their postprandial plasma carotenoid and triglyceride outcomes evaluated
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2026
CompletedFirst Posted
Study publicly available on registry
August 31, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
September 2, 2026
August 1, 2026
5 months
August 26, 2026
August 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Concentration of plasma carotenoids
Concentration of plasma carotenoids hourly
From start of salad consumption to the end of acute period (8 hours)
Concentration of blood triglycerides
Postprandial triglyceride response
From start of salad consumption to the end of acute period (8 hours)
Study Arms (5)
Salad only
PLACEBO COMPARATORSalad only (no protein)
Salad + Chicken
EXPERIMENTALSalad with chicken
Salad + Tuna
EXPERIMENTALSalad with tuna
Salad + Egg
EXPERIMENTALSalad with egg
Salad + Soybean
EXPERIMENTALSalad with soybeans
Interventions
Eligibility Criteria
You may qualify if:
- English-literate and able to give informed consent
- Singaporean Adults aged 21 to 45 (inclusive)
- Body mass index of 18.5 to 23.0 kg/m2 (inclusive)
- At least 50 kg
- Healthy (based on screening results)
You may not qualify if:
- Currently participating in another clinical study that involves altering regular diet and/or involves consuming a dietary supplement or investigated food product as an intervention
- High blood pressure (≥ 140/90 mmHg)
- Underlying health conditions that may affect metabolic functions
- Consuming carotenoid supplements regularly (i.e., more than three times a week) for the past 3 months, and not willing to discontinue consumption 3 months before and during the study duration
- Weight change \> 3 kg in the past 3 months
- Exercising vigorously over the past 3 months (i.e., engaging in high-intensity exercises for more than 3 hours a week, where high-intensity exercises leave one out of breath and unable to talk or sing during the workout)
- Current smokers or have quit smoking for less than 5 years
- Drinking \> 2 alcoholic drinks per day (i.e., one drink is defined as either 150 ml of wine, 340 ml of beer/cider or 45 ml of distilled spirit)
- If drinking ≤ 2 alcoholic drinks per day, not willing to stop consumption of alcoholic beverages two days before and on the day of the test visits
- Not willing to stop consumption of caffeinated beverages 10 to 12 hours before and on the day of the test visits
- Currently on a specialised diet (e.g., vegetarian, vegan, weight loss diet)
- Had serious food allergies in the past, or having intolerance, sensitivities or allergies to any of the following: soy/soy-derived products, eggs, fish and crustaceans, starch/starch-derived products (e.g., rice, corn, wheat, potato), gluten
- Disease or impairment of the liver
- Currently diagnosed with diabetes, gastrointestinal issues (e.g., lactose intolerance, irritable bowel syndrome), gout and/or G6PD deficiency
- Taking antibiotics 2 weeks prior to study participation
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NUS, Department of Food Science and Technology, 1 Science Drive 3, Block S13, #03-07, Singapore, 117542
Singapore, 117542, Singapore
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jung Eun Kim, Ph.D., R.D.
National University of Singapore, Department of Food Science and Technology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 26, 2026
First Posted
August 31, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
September 2, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Electronic copies of the data with identifiable participant information will be kept on NUS OneDrive with access limited only to Dr Kim Jung Eun and her research staff. All data will be de-identified prior to statistical analyses.